Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Chagas Disease Diagnostic - Inconclusive Serology
This study has been completed.
Sponsored by: UPECLIN HC FM Botucatu Unesp
Information provided by: UPECLIN HC FM Botucatu Unesp
ClinicalTrials.gov Identifier: NCT00511589
  Purpose

T. cruzi infection affects approximately five million people in Brazil. The diagnosis of the chronic phase of infection is performed by indirect serological methods which, nevertheless, leave inconclusive results. One of the direct methods used for T. cruzi identification, blood culture in LIT (liver infusion tryptose) medium, presents low sensitivity in that phase of the disease. A negative result does not eliminate the possibility of infection, but a positive test has high absolute diagnostic value, which enables the indication of antiparasitic treatment. Molecular diagnosis (PCR) in this phase is promising and can be used as a confirmatory test, particularly when individuals present inconclusive results in conventional serological tests, such as ELISA, HAI and IFI. This study aimed at improving blood culture sensitivity in LIT medium by performing PCR in individuals with positive and inconclusive serology for chagasic infection.


Condition Intervention
Parasitemia
Protozoan Infections
Other: chagas disease diagnostic

MedlinePlus related topics: Chagas Disease
U.S. FDA Resources
Study Type: Interventional
Study Design: Open Label, Parallel Assignment
Official Title: PCR in Blood Cultures of Individuals With Positive and Inconclusive Serology for Chagas' Disease
  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • individuals with positive or inconclusive results in conventional serological tests: ELISA, HAI and IFI for Chagas disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00511589

Locations
Brazil, São Paulo
Univerdidade Estadual Paulista
Botucatu, São Paulo, Brazil, 18600-000
Sponsors and Collaborators
UPECLIN HC FM Botucatu Unesp
Investigators
Principal Investigator: Mariele Cristina M Picka, MSc UPECLIN HC FM Botucatu Unesp
  More Information

Study ID Numbers: TD00107
Study First Received: August 3, 2007
Last Updated: August 3, 2007
ClinicalTrials.gov Identifier: NCT00511589  
Health Authority: Brazil: National Committee of Ethics in Research

Study placed in the following topic categories:
Systemic Inflammatory Response Syndrome
Chagas disease
Protozoan Infections
Sepsis
Parasitemia
Trypanosomiasis
Parasitic Diseases
Chagas Disease
Inflammation

Additional relevant MeSH terms:
Pathologic Processes
Sarcomastigophora Infections
Mastigophora Infections
Infection

ClinicalTrials.gov processed this record on January 16, 2009